Contact Info

Ron Ben-Menachem

Partner

Ron Ben Menachem is a partner in our firm’s Corporate and Capital Markets Department and he is a member of the firm’s pro bono committee. His practice focuses on private and public offerings, mergers, and acquisitions, with a special emphasis on international transactions.

Ron represents domestic and foreign clients in a broad range of industries, including financial services, technology, pharmaceuticals, energy, and consumer products.
Ron is rated as a “Leading Lawyer” by the International Financial Law Review (IFLR), and was the winner of the “Deal Maker of the Year” award for several of his transactions by Finance Monthly Magazine.

Ron is an adjunct professor at the Reichman University (IDC) teaching a course on Deals & Agreements.

Prior to joining Herzog Fox & Neeman, Ron practiced corporate law with the New York office of Weil, Gotshal & Manges LLP (2004-2011) and clerked for the Honorable Justice Edmund E. Levy, Israel Supreme Court (2001).

Contact Info

Ron Ben-Menachem

“Ron is a very strong capital markets lawyer, who is very devoted to the client and always delivers.”

“Ron Ben-Menachem is a pleasant, smart, helpful and quick practitioner who understands business.”

Chambers and Partners

  • Israel Bar Association, 2001
  • New York Bar Association, 2004
  • IDC, LLB (cum laude), 2000 IDC, BA (Business Administration & Finance), (Summa cum Laude), 2000
  • Columbia Law School, LLM (Summa cum Laude), 2004

• Representing Elbit Systems Ltd. In its $300 million commercial paper offering (October 2023).
• Acting as Israeli counsel for REE Automotive Ltd., in its "At The Market" Sales Agreement with H.C. Wainwright & Co., for the sale of up to $35 million on Nasdaq (June 2023).
• Acting as Israeli counsel to Jefferies in connection with an Open Market Sales Agreement with Arbe Robotics (Nasdaq: ARBE). The agreement allows for offerings of shares, from time to time, of up to $50 million (May 2023).
• Representing NeoGames (Nasdaq: NGMS) in its $1.2B go-private transaction with Aristocrat Leisure (May 2023).
• Representing the controlling shareholders of NeoGames, a Nasdaq listed company in the sale of 10% of the company shares with a market cap of $34.6 million (April 2023)
• Israeli counsel to Goldman Sachs, acting as the sole book running manager of a $340 million equity offering by Ormat Technologies on the NYSE (April 2023).
• Israeli counsel to Citigroup, Goldman Sachs and PNC Capital Markets as the active joint book-running managers of a $2.5 billion sustainable-linked notes offering by Teva Pharmaceuticals Industries (March 2023).
• Enlight Renewable Energy Ltd. in its $306 million Nasdaq IPO (February 2023)
• Citi, Barclays and Jefferies, in $800 million senior bonds offering by Israel Discount Bank (January 2023).
• Bank Leumi, in its $500 million Green Bond offering (January 2023).
• Highbridge Management LLC in its $25 million convertible debt loan to Gamida Cell (October 2022).
• Nayax, in its direct listing on Nasdaq (September 2022)
• Representing Bank Leumi, Israel's largest bank, in a $500 million international senior notes offering. Citibank acted as global coordinator, and J.P. Morgan, Barclays, UBS and Jefferies acted as and co-bookrunners (completed July 2022).
• Representing Bank Leumi, Israel's largest bank, in a $850 million international public equity offering. Citibank acted as global coordinator, and Barclays and Jefferies acted as and co-bookrunners (completed June 2022).
• Representing Barclays Bank, J.P. Morgan, Citigroup, BofA Securities, HSBC, and Goldman Sachs, as joint book-runners managers in a $375 million private offering of 2.50% Green Convertible Senior Notes by Ormat Technologies Inc.
• Representing Israel Electric Corporation in its $500,000,000 144A international bond offering (closed February 2022).
• J.P. Morgan, HSBC, BofA Securities and BNP Paribas as Join Book-Running Managers of $5 Billion Sustainability-Linked Senior Notes offering by Teva Pharmaceuticals Ltd. (completed November 2021).
• NeoGames, in a secondary offering by Caesars Entertainment Inc. of approximately $145 million, led by J.P. Morgan and Deutsche Bank Securities (completed September 2021).
• Serving as Israeli counsel on numerous IPOs and public offerings and initial public offerings including by Varonis Systems, Magic Software Enterprises, Imperva, Radcom, AudiCodes, Foamix Pharmaceuticals, Entera Bio, and others.
• NeoGames, as Israeli's issuer counsel, in its NASDAQ IPO (November 2020).
• Terminal X, in its $85 million IPO on TASE, providing a company valuation of approximately of approximately $390 million, in an offering that included international underwriting led by UBS (July 2021).
• Elbit Systems Ltd., in its ILS 1.9 billion (approximately $560 million), notes offering on the Tel Aviv Stock Exchange (June 2021).
• Retailors Ltd., in its ILS 570 million (approximately $173 million) IPO and listing the Tel Aviv Stock Exchange, in an offering that was opened for international investors via international underwriting let by UBS; the IPO represented a pre-IPO company valuation of ILS1.8 billion (May 2021),
• Nayax Ltd., in its IPO and listing on Tel Aviv Stock Exchange. That was the first ever unicorn IPO on TASE, and the largest technology offering ever on TASE; the offering was a global offering, underwritten by Jefferies and sold to U.S. and EU investors (completed May 2021).
• Jefferies LLC, regarding a block trade of the shares of Gilat Satellite Networks Ltd., a Nasdaq and TASE listed company (completed February 2021).
• Highbridge Capital, as initial purchase of $75 million notes, issued by Gamida Cell Ltd. (February 2021)
• PlayStudios, as Israeli counsel, in connection with their De-SPAC transaction, at a valuation of $1.1 billion (completed February 2021).
• ValueBase, an Israeli investment bank, in connection with its role in the formation of a SPAC. (completed January 2021)
• Max Stock and Apax partners in the Initial Public Offering of Max Stock on the Tel-Aviv stock Exchange (completed September 2020)
• Cellcom Israel Ltd., a dually listed telecommunication company, in its NIS300 million offering of shares and options (completed December 2019) and NIS200 million notes offering (completed May 2020)
• Bank Leumi in its $750 million tier two international bond offering (completed January 2020)
• Jefferies LLC, as lead-underwriter of the Tel-Aviv Stock Exchange Initial Public Offering (completed July 2019).
• Israeli counsel to Goldman Sachs, Citigroup and BNP Paribas as underwriters of a $1.5 billion international bond offering by Teva Pharmaceuticals (completed November 2019).
• Israeli counsel to Citigroup and BNP Paribas as underwriters of a $22B public offering of debt, by Teva Pharmaceuticals, the largest debt offering by an Israeli company ever (completed July 2017).
• Israeli counsel to Citigroup and Morgan Stanley, as underwriters of $6.75B public offering of equity, by Teva Pharmaceuticals, the largest equity offering by an Israeli company ever (completed December 2015).
• Adama Agricultural Solutions, as company’s counsel, in its Initial Public Offering on the New York Stock Exchange (November 2014; incomplete).
• Lead counsel to Elbit Systems in a $185,000,000 offering conducted as a PIPE and listing on Nasdaq.
• Israel Electric Corporation, as company’s counsel, in several 144A/Reg. S. public offerings, in an aggregate value of over $3B (November 2014, June 2013 and February 2012);
• Nayax, in its acquisition of On Track Innovation Ltd., out of insolvency proceedings (March 2022).
• NeoGames, a Luxembourg company whose shares are listed on Nasdaq, in the public tender offer to acquire the entire share capital of Aspire Global plc., a Malta company whose shares are listed on Nasdaq North, for an aggregate consideration of approximately $500 million (January 2022).
• Representing Sphera Fund, in its pre-IPO SAFE investment in More Pension Funds (completed October 2021)
• Representing WeWork in the sale of its business in Israel to Ampa (April 2021)
• Representing a group of investors in the acquisition of the Third Ear, a Tel-Aviv music and entertainment institution (completed July 2020).
• Mellanox, in the $800 million acquisition of EZChip Ltd. (both Nasdaq listed).

  • Leading Partner in Capital Markets (The Legal 500 2025).
  • Ranked in Capital Markets (Chambers Global 2025)
  • Highly Regarded in Capital Markets (IFLR1000, 2025).
  • Foreign Expertise based abroad in Capital Markets: Debt & Equity (Chambers Global 2025).
  • Leading Individual in Capital Markets (The Legal 500 2024).
  • Ranked in Capital Markets (Chambers Global 2024)
  • Foreign Expertise based abroad in Capital Markets: Debt & Equity (Chambers Global 2024).
  • Highly Regarded in Capital Markets (IFLR1000, 2023).
  • Recommended Lawyer in Capital Markets (The Legal 500 2023).
  • Foreign Expertise based abroad in Capital Markets: Debt & Equity (Chambers Global 2023).
  • Highly Regarded in Capital Markets (IFLR1000, 2022).
  • Recommended Lawyer in Capital Markets (The Legal 500 2022).
  • Foreign Expertise based abroad in Capital Markets: Debt & Equity (Chambers Global 2022).
  • Highly Regarded in Capital Markets (IFLR1000, 2021).
  • Winner of the "Deal Maker of the Year Award" by the Finance Monthly Magazine.
JOIN OUR
Newsletter

    © 2020, All rights reserved, Herzog Law
    Site by Gootte

    The information contained in this web site is provided for informational purposes only and should not be construed as legal advice on any subject matter and should not be relied upon as such. Herzog accepts no responsibility for any consequences whatsoever arising from use of the information contained in this web site. The accessing of information contained in this web site shall under no circumstances be considered as creating an attorney-client relationship between Herzog and any party accessing this web site. Contacting through email any lawyer named in this web site or sending information without prior agreement of Herzog shall not be construed as automatically creating an attorney-client relationship between Herzog and the party sending an email or information. The material contained in this web site has been created by and remains the property of Herzog. No reproduction, transmission, publication or any other form of dissemination shall be permitted unless the prior written consent of Herzog has been obtained. This web site may contain links to other web sites operated by third parties. Herzog does not sponsor, approve or endorse the content of any such web site and is not responsible for the materials appearing in such sites.